Skip to main content

Where our founders, teams, and ideas move the future forward.

Health & Bio
Backing Samphire Neuroscience
Today we’re thrilled to share our investment in Samphire Neuroscience, a company redefining the future of women’s health. They’re starting with one of the most overlooked yet widely experienced chronic conditions affecting hundreds of millions of people worldwide: PMS and PMDD.
Backing Valo.ai to solve SaaS chaos
Canatu to become public
Backing Steep to revolutionize analytics
Building in healthcare: Insights from the founder of Medoma
Backing Reveel to transform tourism
How is AI transforming healthcare
Lassie: From seed to series B
Backing Ultihash
Backing getpaid to fix B2B payments
Backing Starcart (again)
Inventure IV final close: A small update on a big milestone
Backing Algorighmiq
The new normal
Announcing our investment in Value.Space
Haltian: Getting to 50% growth in the hardware industry
Data opportunities in the wake of generative AI
The next industrial titans will be software companies
Navigating your first international expansion
Linus Dahg takes on new role as Inventure’s CEO
Inventure’s Timo Tirkkonen on the aiMotive story
Inventure IV

ESG & Sustainability

Igniting the few to accelerate the many

‍

You can download our 2025 Portfolio Survey and ESG report.

For more info, here is Inventure’s ESG & Responsible Investment Policy. Further information on general compliance & SFDR can be found in our compliance information sheet.

LinkedInNewsletter
Copyright © 2025 Inventure